The NCRI Lymphoma Group has five study groups that develop research in areas of strategic need.
The High-Grade Lymphoma Study Group, chaired by Dr Christopher Fox, develops research into cancer of the lymph nodes that grows and spreads quickly.
Members:
Christopher Fox, Consultant Haematologist, Nottingham University Hospitals NHS Trust (study group chair)
Matthew Ahearne, Trainee, University Hospitals of Leicester NHS Trust
Arzhang Ardavan, NCRI Consumer Forum member, Professor of Physics
Kirit Ardeshna, University College London Hospitals NHS Foundation Trust (UCLH)
Sally Barrington, Professor of PET Imaging, King’s College London (KCL)
Kaljit Bhuller
Gladstone Amos Burke, NIHR CRN: Cancer National Specialty Lead for Children & Young People’s Cancer, University of Cambridge
Cathy Burton, Pathologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary
Maria Calaminici, Consultant, Barts Health NHS Trust
Robert Carr
Sridhar Chaganti, Consultant Haematologist, Queen Elizabeth Hospital Birmingham
Laura Clifton-Hadley, Trials Group Leader, University College London (UCL)
Graham Collins, Oxford University Hospitals NHS Foundation Trust
Christina Cox
Thomas Cummin, Clinical Research Fellow/ Specialist Registrar Haematology, University of Southampton
David Cunningham, Consultant Medical Oncologist, Head of the Gastrointestinal and Lymphoma Unit and Director of Clinical Research, Royal Marsden NHS Foundation Trust
Kate Cwynarski, Consultant Haematologist, University College London Hospitals NHS Foundation Trust (UCLH)
Andrew Davies, Associate Professor And Consultant In Medical Oncology, University Hospital Southampton NHS Foundation Trust – Princess Anne Hospital
Jeff Davies
Ming-Qing Du
Jurate Dudley, Clinical Trials Officer, Guy’s and St Thomas’ NHS Foundation Trust
Martin Dyer, Professor of Haemato-Oncology, University Hospitals of Leicester NHS Trust
David Edwards
Dima El-Sharkawi
Linda Evans, Sheffield Teaching Hospitals NHS Foundation Trust
Paul Fields, Consultant Haematologist, Guy’s and St Thomas’ NHS Foundation Trust
George Follows, Consultant Haematologist, Addenbrooke’s Hospital NHS Foundation Trust
Sonia Fox, University of Birmingham
Mary Gleeson
Daniel Hodson, Honorary Consultant Haematologist, University of Cambridge
Tim Illidge, Clinical Oncologist Professor of Targeted Therapy & Oncology, Head of Division of Cancer Sciences, University of Manchester
Sunil Iyengar
Rod Johnson
Nagesh Kalalonda, University of Liverpool
Shireen Kassam
Amy Kirkwood, Senior Statistician, Cancer Research UK (CRUK) London – Clinical Trials Unit @ University College London (UCL)
Andrea Kuhnl
Jonathan Lambert, University College London Hospitals NHS Foundation Trust (UCLH)
Dr David Lewis, Plymouth Hospitals NHS Trust
Sean Lim, Associate Professor and Honorary Consultant in Haematological Oncology, No affiliation
David Linch
Kim Linton, Honorary Consultant in Medical Oncology, University of Manchester
Maria Marzolini, , University College London (UCL)
Pam McKay, NHS Greater Glasgow and Clyde
Tobias Menne, Newcastle upon Tyne Hospitals NHS Foundation Trust
George Mikhaeel, Clinical Lead – Clinical Oncology, Guy’s and St Thomas’ NHS Foundation Trust
Jessica Okosun, Queen Mary University of London
Wendy Osborne, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Foundation Trust
Wendy Osborne, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Foundation Trust
Ann Parfett
Russell Patmore, Hull Royal Infirmary
Ruth Pettengell, Consultant, St George’s, University of London
Andrew Pettitt, Professor of Haematology Molecular and Clinical Cancer Medicine, University of Liverpool
Beth Phillips, Lymphoma Clinical Trials Fellow, University College London (UCL)
John Radford, Professor of Medical Oncology, University of Manchester
Emma Searle, Clinical Lecturer and Honorary Consultant Haematologist, University of Manchester
Nimish Shah, Consultant Haematologist, University of East Anglia (UEA)
Oonagh Sheehy, Consultant Haematologist, Belfast City Hospital
Shamyla Siddique, Haematology Trials Team Leader, University of Birmingham
Dr Jeff Smith, Aintree University Hospital
Louise Stanton, Principal Medical Statistician, University of Southampton
Mary Taj, Institute of Cancer Research (ICR)
Simon Wagner
Renata Walewska
Harriet Walter, Spr Medical Oncologycancer Research Uk And Clinical Trials Fellow, University Hospitals of Leicester NHS Trust
Andrew Webb, Consultant Oncologist, Brighton and Sussex University Hospitals NHS Trust
The Hodgkin Lymphoma Study Group, chaired by Dr Catherine Burton, develops research into cancer of the lymphatic system.
Members:
Cathy Burton, Pathologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary (study group chair)
Arzhang Ardavan, NCRI Consumer Forum member, Professor of Physics
Sally Barrington, Professor of PET Imaging, King’s College London (KCL)
Graham Collins, Oxford University Hospitals NHS Foundation Trust
Laura Clifton-Hadley, Trials Group Leader, University College London (UCL)
David Cutter, Consultant Clinical Oncologist and Clinical Research Fellow, Oxford University Hospitals NHS Foundation Trust
Eve Gallop-Evans, Velindre Cancer Centre
Georgina Hall
Sunil Iyengar
Ruth Jarrett, Professor of Molecular Pathology, University of Glasgow
Craig Jones
Amy Kirkwood, Senior Statistician, Cancer Research UK (CRUK) London – Clinical Trials Unit @ University College London (UCL)
Andrea Kuhnl
Rifca Le Dieu
Chiara Lobetti
Ram Malladi, Consultant Haematologist, Addenbrooke’s Hospital NHS Foundation Trust
Pam McKay, NHS Greater Glasgow and Clyde
Andrew McMillan, Consultant Haematologist, Nottingham University Hospitals NHS Trust
Patrick Medd, King’s College London (KCL)
Fiona Miall, University Hospitals of Leicester NHS Trust
Jessica Okosun, Queen Mary University of London
Wendy Osborne, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Foundation Trust
Shankara Paneesha
Karl Peggs, University College London (UCL)
Andrew Pettitt, Professor of Haematology Molecular and Clinical Cancer Medicine, University of Liverpool
Beth Phillips, Lymphoma Clinical Trials Fellow, University College London (UCL)
John Radford, Professor of Medical Oncology, University of Manchester
Nimish Shah
Ananth Shankar, Honorary Senior Lecturer & Consultant in Paediatric & Adolescent Oncology, University College London Hospitals NHS Foundation Trust (UCLH)
Louise Stanton, Principal Medical Statistician, University of Southampton
Amit Sud, Institute of Cancer Research (ICR)
Ghada Zakout
The Low-Grade Lymphoma Study Group, chaired Dr Kim Linton, develops research into cancer of the lymph nodes that is usually very slow-growing.
Members:
Kim Linton, Honorary Consultant in Medical Oncology, University of Manchester (study group chair)
Kirit Ardeshna, University College London Hospitals NHS Foundation Trust (UCLH)
Nicola Bienz, Heatherwood and Wexham Park Hospital
Dr Mark Bishton, Nottingham University Hospitals NHS Trust
Toby Eyre, University of Oxford
Peter Hoskin, Professor of Clinical Oncology, Mount Vernon Cancer Centre
Sunil Iyengar
Chiara Lobetti
Pam McKay, NHS Greater Glasgow and Clyde
Dr Geetha Menon, Haematopathologist, Liverpool University Hospitals NHS Foundation Trust
Jessica Okosun, Queen Mary University of London
Andrew Pettitt, Professor of Haematology Molecular and Clinical Cancer Medicine, University of Liverpool
Malcolm Rhodes, NCRI Consumer Forum member
Renata Walewska
The Health Data Lymphoma Study Group, chaired Dr David Cutter, aims to improve the quality and impact of research related to health data, provide complimentary data to clinical trials and avoid duplication of work.
Members:
Dr David Cutter, Consultant Clinical Oncologist, University of Oxford (study group chair)
Dr Mark Bishton Consultant Haematologist, University of Nottingham (study group deputy chair)